AbbVie Inc (ABBV) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $224.66
• Market Cap: $401.23B
• P/E Ratio: 96.15
• EPS: $2.36
• Dividend Yield: 0.03%
• 52-Week High: $241.12
• 52-Week Low: $159.05

Market Sentiment

AbbVie Inc currently has a Bullish sentiment score of 0.27.

About AbbVie Inc

AbbVie Inc is a leading American biopharmaceutical company, established in 2013 from a spin-off of Abbott Laboratories. The company specializes in the research, development, and commercialization of advanced therapies in immunology, oncology, virology, and neuroscience. With a robust pipeline of innovative treatments, AbbVie is committed to addressing some of the world's most challenging health issues and is recognized for its blockbuster immunology drug, Humira. AbbVie continues to strengthe...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for AbbVie Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is ABBV's current dividend yield?

AbbVie Inc (ABBV) has a current dividend yield of 0.03%.

Does ABBV pay dividends?

Yes, AbbVie Inc pays dividends with a current yield of 0.03%.

What is ABBV's P/E ratio?

AbbVie Inc has a price-to-earnings (P/E) ratio of 96.15.

What is ABBV's market cap?

AbbVie Inc (ABBV) has a market capitalization of $401.23B with a current stock price of $224.66.